Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling (2019)

Peer-Reviewed Study · Diao H; Cheng N; Zhao Y; Xu H; Dong H; Thamm DH; Zhang D; Lin D · August 2, 2019

Diao H et al., 2019-08-02: Canine mammary tumour cell lines and mouse xenografts showing dose- and time-dependent growth inhibition with G1 arrest, reduced beta-catenin nuclear translocation and WNT inactivation, but no significant induction of apoptosis.

Furthermore, significantly reduced β-catenin nuclear translocation was observed after treatment with ivermectin, resulting in the inactivation of WNT signaling.

n/a (HTML full text)

Diao H et al., 2019-08-02: Canine mammary tumour cell lines and mouse xenografts showing dose- and time-dependent growth inhibition with G1 arrest, reduced beta-catenin nuclear translocation and WNT inactivation, but no significant induction of apoptosis. Study type: canine cell lines + mouse xenograft. N: 6 mice per group. Country: China (China Agricultural University, Beijing); co-author Thamm DH is at Colorado State University, USA. Dose: 0.1 mg per mouse (approximately 6-7 mg/kg) daily intraperitoneal for 27 days; comparator: vehicle. Funder: National Natural Science Foundation of China grants 31572578 and 31402260. Declared COI: 'The authors declare that they have no competing interests.' Study type: animal.